Financials
- Market Capitalization 2.02 B
- Employee 293
- Founded 2017
- CEO N/A
- Website www.harmonybiosciences.com
- Headquarter Delaware, United States
- FIGI BBG00WBPG4C2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
13.81
Relación precio/flujo de caja
2.52
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1980 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 18.20 USD | +4.54% | +1.85% | +19.74% | +123.59% | 2.02 B USD | ||
| 1983 | NBTX Nanobiotix S.A. - ADSs | 41.64 USD | +6.36% | +10.25% | +17.63% | +690.13% | 2.02 B USD | ||
| 1992 | GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 23.46 USD | +6.73% | -2.21% | +30.04% | +107.61% | 1.98 B USD | ||
| 1997 | VRDN Viridian Therapeutics, Inc. - Common Stock | 19.08 USD | +0.47% | -5.17% | +17.13% | -15.01% | 1.97 B USD |